Ophthalmology Management

01/26/2026

Dry eye relief - without preservatives 💧

Focus Vitamins has launched Focus Tears PF Eye Drops, preservative-free artificial tears designed to deliver fast, soothing comfort for dry, irritated, or sensitive eyes. Convenient single-dose vials make relief easy anytime, anywhere.

👉 Learn more about this new launch: https://ow.ly/kZaA50Y0w4f

01/23/2026

💡 Leadership isn’t granted by a title - it’s built through influence.

In Ophthalmology Management, Mandy Cansler, COMT, COE, LSSGB explains how technicians lead without formal titles by shaping clinic flow, culture, and patient experience through everyday actions.

They don’t wait for permission, they lead where they stand.

👉 Read for more insights: https://ow.ly/2jNt50XWG3w

01/21/2026

After decades of recurring symptoms from plasminogen deficiency type 1 (PLGD-1), a 51-year-old patient finally found lasting relief. Read on to learn how regular infusions have stabilized her vision and systemic health: https://bit.ly/4hOyfqz

01/21/2026

🧾 Are you using modifier -25 correctly?

In Ophthalmology Management, Mary Pat Johnson, COMT, CPC, COE, CPMA, explains when modifier -25 is appropriate - and when it’s not - with clear examples every ophthalmic practice should review.

🔍 CMS scrutiny is increasing
📉 Overuse carries real risk
📚 Documentation makes the difference

Now is the time to review guidance, educate your team, and confirm your billing holds up under audit.

👉 Read the full article and protect your practice: https://ow.ly/9pUJ50XWFVF

01/20/2026

📰 New OTC option for allergy eye relief

Dr. Reddy’s has launched olopatadine hydrochloride ophthalmic solution USP, 0.7%, the FDA-approved OTC generic equivalent of Extra-Strength Pataday Once-Daily Relief in the US.

The antihistamine eye drop is indicated for the temporary relief of itchy eyes caused by pollen, ragweed, grass, and animal dander.

Read more: https://ow.ly/Jhn550Y09Cy

01/16/2026

📊 New clinical evidence in Infantile Nystagmus care

A randomized controlled study published in the British Journal of Ophthalmology demonstrates that RevitalVision’s FDA-cleared digital therapeutic significantly improves visual acuity, contrast sensitivity, and functional vision in patients with infantile nystagmus.

🔹 46% achieved 20/40 driving-level vision
🔹 Improvements in binocular vision, stereoacuity & night vision
🔹 Strong patient-reported impact on daily functioning

👉 Read the full article and explore what this could mean for your patients: https://ow.ly/HqpX50XWCS6

01/15/2026

🧠 Interventional glaucoma isn’t just a procedure - it’s a culture shift.

In Ophthalmology Management, Melissa Ciccarelli, COE, practice administrator at Dell Laser Consultants, draws powerful parallels between today’s interventional glaucoma moment and past inflection points like LASIK and premium IOLs.

From coordinators who reframe patient conversations, to teams trained to reduce clinical and financial barriers, Ciccarelli outlines how administrators can lead the transition from reactive glaucoma care to earlier, more proactive intervention.

👉 Read the full piece for more insights: https://ow.ly/WGHl50XWFGv

01/14/2026

🚨 FDA clears Rayner’s Sophi Phaco system

Rayner has received FDA 510(k) clearance for Sophi, its Swiss-engineered phacoemulsification system designed for ASCs, office-based surgery, and hospital settings.

Rayner say that Sophi offers faster setup, quicker patient turnover, and greater mobility, with features including triple pump fluidics and a wireless power concept.

👉 Read more: https://ow.ly/ANR750XWGum

01/13/2026

🎉 Celebrating 30 years of Ophthalmology Management

This year marks 30 years of supporting ophthalmologists at the intersection of clinical care, surgical innovation, and practice.

Thank you to our editorial teams, contributors, and readers for being part of this journey.
🔗 https://ow.ly/qFBR50XWapW

01/09/2026

Post-op outcomes start before surgery. 👁️

In this article, Vance Thompson, MD explains why optimizing the ocular surface before and after surgery is key to reducing Surgical Temporary Ocular Discomfort Syndrome (STODS) and improving visual quality and patient satisfaction.

STODS is common, usually temporary, and often overlooked. Proactive screening, treatment, and surgical technique can make a real difference.

🔗 Read more: https://ow.ly/QYJq50XN57g

STODS can negatively impact patient satisfaction and surgical outcomes. Surgeons can reduce patient burden by identifying at-risk patients; optimizing the ocular surface before surgery; adopting surgical techniques that minimize disruption to the ocular surface; and managing postoperative symptoms p...

01/08/2026

Marketing budgets may be tight, but expectations for results have never been higher.

In this article, Amanda Robben, COE, shares practical, real-world strategies for ophthalmology practices to make every marketing dollar count, from smarter media choices and intentional social content to patient retention and low-cost in-office events.

🔗 Read the article: https://ow.ly/jVhc50XN534

Whether it’s shifting your media strategy, improving follow-up systems, or hosting community focused events, thriving on a limited marketing budget is possible.

01/06/2026

New global guidance on myopia is reshaping how we approach care. 🌍👁️

The International Myopia Institute 2025 Digest brings expert consensus on myopia definitions, risk factors, prevention, and management with a strong focus on early identification, personalized treatment, and lifestyle interventions.

Key takeaways for eye care professionals:
👁‍🗨 Pre-myopia matters. Hyperopic reserve is a critical predictor of future myopia
👁‍🗨 Delay equals protection. Each year onset is delayed can prevent years of progression
👁‍🗨 Outdoor time works. It remains the strongest protective factor
👁‍🗨 Personalized care wins. Optical interventions and risk-based strategies are supported by long-term evidence

As myopia rates rise worldwide, this guidance reinforces the importance of proactive, patient-centered care starting early. Read more in Ophthalmology Management: https://ow.ly/JlkB50XRQeJ